ChiCTR2100053679 版本V1.1 版本创建时间2022/05/27 17:46:44 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100053679 

最近更新日期:

Date of Last Refreshed on:

2021-11-27 08:35:35 

注册时间:

Date of Registration:

2021-11-27 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

3D打印联合数字化混合现实技术(MR)重建前交叉韧带的精准化临床研究

Public title:

Accurate clinical study of 3D printing combined with digital mixed reality (MR) reconstruction of anterior cruciate ligament

注册题目简写:

English Acronym:

研究课题的正式科学名称:

3D打印联合数字化混合现实技术(MR)重建前交叉韧带的精准化临床研究

Scientific title:

Accurate clinical study of 3D printing combined with digital mixed reality (MR) reconstruction of anterior cruciate ligament

研究课题代号(代码):

Study subject ID:

2019CXLCC017

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王敬琨 

研究负责人:

熊雁 

Applicant:

Jingkun Wang 

Study leader:

Yan Xiong 

申请注册联系人电话:

Applicant telephone:

15723059018

研究负责人电话:

Study leader's telephone:

13228686341

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

841526885@qq.com

研究负责人电子邮件:

Study leader's E-mail:

xiongyan815@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区长江支路10号陆军特色医学中心

研究负责人通讯地址:

重庆市渝中区长江支路10号陆军特色医学中心

Applicant address:

Army Medical Center of PLA, No. 10 Yangtze River Branch Road, Yuzhong District, Chongqing

Study leader's address:

Army Medical Center of PLA, No. 10 Yangtze River Branch Road, Yuzhong District, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

陆军特色医学中心

Applicant's institution:

Army Medical Center of PLA

研究负责人所在单位:

陆军特色医学中心

Affiliation of the Leader:

Army Medical Center of PLA

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

医研伦理(2020)第88号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军陆军特色医学中心伦理委员会

Name of the ethic committee:

Ethics Committee of Army Medical Center of PLA

伦理委员会批准日期:

Date of approved by ethic committee:

2021-06-24 00:00:00

伦理委员会联系人:

廖祥丽

Contact Name of the ethic committee:

XiangLi Liao

伦理委员会联系地址:

重庆市渝中区长江支路10号陆军特色医学中心

Contact Address of the ethic committee:

Army Medical Center of PLA, No. 10 Yangtze River Branch Road, Yuzhong District, Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

68757140

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

陆军特色医学中心

Primary sponsor:

Army Medical Center of PLA

研究实施负责(组长)单位地址:

重庆市渝中区长江支路10号陆军特色医学中心

Primary sponsor's address:

Army Medical Center of PLA, No. 10 Yangtze River Branch Road, Yuzhong District, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

陆军特色医学中心

具体地址:

渝中区长江支路10号

Institution
hospital:

Army Medical Center of PLA

Address:

10 Yangtze River Branch Road, Yuzhong District

经费或物资来源:

陆军特色医学中心人才创新能力培养计划

Source(s) of funding:

The Talent Innovation ability training Program of Army Medical Center of PLA

Target disease:

Anterior cruciate ligament injury

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

利用3D打印联合数字化混合现实技术(MR)辅助重建前交叉韧带,提高前交叉韧带重建术中股骨、胫骨隧道定位点的准确性。  

Objectives of Study:

3D printing combined with digital hybrid reality (MR) was used to reconstruct anterior cruciate ligament (ACL) to improve the accuracy of femoral and tibial tunnel location in ACL reconstruction.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1、前交叉韧带损伤;2、行关节镜下取自体肌腱前交叉韧带重建;3、18至60岁的患者

Inclusion criteria

1. Injury of anterior cruciate ligament;
2. Anterior cruciate ligament reconstruction with autologous tendon under arthroscopy;
3. Patients aged from 18 to 60 years old.

排除标准:

1、合并其他韧带损伤;2、异体肌腱重建;3、小于18岁或大于60岁

Exclusion criteria:

1 combined with other ligament injuries;
2 allogeneic tendon reconstruction;
3 less than 18 years old or more than 60 years old

研究实施时间:

Study execute time:

From 2021-11-23 00:00:00 To 2023-01-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-11-23 00:00:00 To 2023-11-01 00:00:00  

干预措施:

Interventions:

组别:

试验组

样本量:

20

Group:

Experimental group

Sample size:

干预措施:

MR辅助下前交叉韧带重建

干预措施代码:

Intervention:

Anterior cruciate ligament reconstruction assisted by MR

Intervention code:

组别:

对照组

样本量:

20

Group:

Control group

Sample size:

干预措施:

标准术式行前交叉韧带重建,不使用MR辅助

干预措施代码:

Intervention:

Standard operation for anterior cruciate ligament reconstruction without MR assistance

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

Chine 

Province:

Chongqing 

City:

 

单位(医院):

陆军特色医学中心 

单位级别:

三级甲等 

Institution
hospital:

Army Medical Center of PLA

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

股骨隧道长度

指标类型:

主要指标

Outcome:

femoral tunnel length

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

股骨隧道位置

指标类型:

主要指标

Outcome:

femoral tunnel position

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

No

Randomization Procedure (please state who generates the random number sequence and by what method):

No

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

及时公开;电子邮件

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

real time access;E-mail

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表;ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form;ResMan

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-11-27 08:34:41